April 9, 2023-April 10, 2023 14th Annual Patient-Reported Outcome Consortium Workshop April 19 – 20, 2023 DoubleTree by Hilton Silver Spring DC North 8777 Georgia Avenue Silver Spring, MD 20910 On April 19–20, 20
March 29, 2023 C-Path Appoints Key Scientific Leaders to Executive Roles Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..
March 16, 2023 Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature According to the latest guidelines by the Infectious Disease Society of America (IDSA), there is no defined standard of care for..
March 15, 2023 View Now | CP-RND: An Introduction to the Patient Community Hosted by the C-Path team, you can view this recorded webinar to learn more about the Critical Path for Rare Neurodegenerative Dis
March 15, 2023 Evaluation of Novel Urinary Biomarkers in Beagle Dogs With Amphotericin B-Induced Kidney Injury
March 15, 2023 Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction...
March 14, 2023 C-Path Welcomes BioCentury Inc. Co-Founder Bernstein to Board of Directors Dr. Bernstein will help steer the strategic vision of C-Path as the organization’s newest board member TUCSON, Ariz., March 14,
March 8, 2023 Establishing a Basis for Secondary Use Standards for Clinical Trials Study seeks to understand how different forms of data meet the needs of researchers.
February 22, 2023 Breaking Down Barriers in Support of Patients with Rare Diseases You’re invited to join C-Path’s Gina Calarco Smith at the upcoming Breaking Down Barriers in Support of Ra
February 20, 2023 3rd PSTC Japan Safety Biomarker Workshop (presentations available) 2023 Presentations PMDA’s Perspective on the Evaluation of Novel Biomarkers (Hisanao Izumi, PhD) Biomolecular Needling System fo
